Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial

Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial

BackgroundTo prevent COVID-19 progression, low-cost alternatives that are available to all patients are needed. Diverse forms of thermotherapy have been proposed to prevent progression to severe/critical COVID-19.ObjectiveThe aim of this study is to evaluate the efficacy and safety of local thermoth...

Full description

Bibliographic Details
Main Authors: Javier Mancilla-Galindo, Ashuin Kammar-García, María de Lourdes Mendoza-Gertrudis, Javier Michael García Acosta, Yanira Saralee Nava Serrano, Oscar Santiago, Miriam Berenice Torres Vásquez, Daniela Martínez Martínez, Liliana Aline Fernández-Urrutia, Julio César Robledo Pascual, Iván Daniel Narváez Morales, Andrea Aida Velasco-Medina, Javier Mancilla-Ramírez, Ricardo Figueroa-Damián, Norma Galindo-Sevilla
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Medicine
Subjects:
thermotherapy
non-oncologic applications of hyperthermia
COVID-19
SARS-CoV-2
hypoxemic respiratory failure
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1256197/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1256197/full

Similar Items